Singapore, Aug 26, 2010: HalcyGen Pharmaceuticals, Australia, has signed a distribution agreement with Pan-Malayan Pharmaceuticals for the distribution of Doryx, Astrix and Eryc in Singapore.

HalcyGen’s CEO, Dr Roger Aston said: “This distribution agreement will expand our sales in Asia. Pan-Malayan is a well respected sales and distribution organization, and we are very pleased to have this company work with us.”

Dorxy and Eryc are oral antibiotics and Astrix is low-dose aspirin. These products, which incorporate Mayne Pharma’s proprietary drug delivery technology, are manufactured at the company’s facility in Salisbury, South Australia.